HIP
AMRX icon

HUB Investment Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

HUB Investment Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Hold
16,044
– – ﹤0.01% 1003
2025
Q4 		$202K Hold
16,044
– – 0.01% 845
2025
Q3 		$161K Hold
16,044
– – 0.01% 729
2025
Q2 		$130K Hold
16,044
– – ﹤0.01% 662
2025
Q1 		$134K Hold
16,044
– – 0.01% 572
2024
Q4 		$127K Hold
16,044
– – 0.01% 529
2024
Q3 		$133K Buy
16,044
+1,044
+7% +$8.16K 0.01% 499
2024
Q2 		$95.3K Hold
15,000
– – ﹤0.01% 474
2024
Q1 		$90.9K Hold
15,000
– – 0.01% 463
2023
Q4 		$91K Buy
+15,000
New +$66.8K 0.01% 392

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

HUB Investment Partners's AMRX Position: Q1 2026 in Review

HUB Investment Partners held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 16,044 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

HUB Investment Partners first reported a position in AMRX in Q4 2023 and has held it in 10 quarters since. The position peaked at $202K in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • HUB Investment Partners held 16,044 shares of Amneal Pharmaceuticals worth $199K as of Q1 2026.
  • HUB Investment Partners left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of HUB Investment Partners's portfolio in Q1 2026, its #1003 holding.
  • HUB Investment Partners first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • HUB Investment Partners's Amneal Pharmaceuticals position peaked at $202K in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.